Tandem Diabetes Care Inc. (TNDM)
NASDAQ · Healthcare
Tandem Diabetes Care Inc. EBITDA 2012–2025
Tandem Diabetes Care Inc. annual/quarterly ebitda history and growth rate from 2012 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Tandem Diabetes Care Inc. ebitda for the quarter ending March 31, 2026 was -12.9 M, a 88.91% decrease year-over-year.
- Tandem Diabetes Care Inc. ebitda for the twelve months ending March 31, 2026 was -291.6 M, a 789.86% increase year-over-year.
- Tandem Diabetes Care Inc. annual ebitda for 2025 was -169.6 M, a 105.52% increase from 2024.
- Tandem Diabetes Care Inc. annual ebitda for 2024 was -82.5 M, a 62.06% decrease from 2023.
- Tandem Diabetes Care Inc. annual ebitda for 2023 was -217.5 M, a 177.03% increase from 2022.
- Tandem Diabetes Care Inc. annual ebitda for 2022 was -78.5 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tandem Diabetes Care Inc. EBITDA — FAQ
Tandem Diabetes Care Inc. (TNDM) ebitda over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TNDM's ebitda history?
The chart and table above show Tandem Diabetes Care Inc.'s ebitda by year and by quarter, including the growth rate.